BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37334663)

  • 1. Fibroblast-derived exosomal microRNA regulates NKX3-1 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells.
    Matsuda C; Ishii K; Nakagawa Y; Shirai T; Sasaki T; Hirokawa YS; Iguchi K; Watanabe M
    J Cell Biochem; 2023 Aug; 124(8):1135-1144. PubMed ID: 37334663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cells.
    Sasaki T; Yoshikawa Y; Kageyama T; Sugino Y; Kato M; Masui S; Nishikawa K; Inoue T
    Prostate; 2023 Mar; 83(4):364-375. PubMed ID: 36479717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient-derived fibroblasts.
    Ishii K; Nakagawa Y; Matsuda C; Katoh D; Ichishi M; Shirai T; Hirokawa Y; Fujiwara M; Sugimura Y; Watanabe M
    J Cell Biochem; 2021 Jun; 122(6):679-688. PubMed ID: 33480080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation.
    Ishii K; Sasaki T; Iguchi K; Kajiwara S; Kato M; Kanda H; Hirokawa Y; Arima K; Mizokami A; Sugimura Y
    Prostate; 2018 Aug; 78(11):849-856. PubMed ID: 29707793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration.
    Ishii K; Matsuoka I; Sasaki T; Nishikawa K; Kanda H; Imai H; Hirokawa Y; Iguchi K; Arima K; Sugimura Y
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31484364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
    Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
    Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells.
    Ishii K; Mizokami A; Tsunoda T; Iguchi K; Kato M; Hori Y; Arima K; Namiki M; Sugimura Y
    J Cell Biochem; 2011 Dec; 112(12):3604-11. PubMed ID: 21809373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
    Thomas MA; Preece DM; Bentel JM
    Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
    Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
    Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
    Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
    J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
    Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
    Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
    Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
    Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.
    Kumar B; Khaleghzadegan S; Mears B; Hatano K; Kudrolli TA; Chowdhury WH; Yeater DB; Ewing CM; Luo J; Isaacs WB; Marchionni L; Lupold SE
    Oncotarget; 2016 Nov; 7(45):72593-72607. PubMed ID: 27683042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
    Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
    Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
    Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
    Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.